percutaneous coronary intervention

Summary

Summary: A family of percutaneous techniques that are used to manage CORONARY OCCLUSION, including standard balloon angioplasty (PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY), the placement of intracoronary STENTS, and atheroablative technologies (e.g., ATHERECTOMY; ENDARTERECTOMY; THROMBECTOMY; PERCUTANEOUS TRANSLUMINAL LASER ANGIOPLASTY). PTCA was the dominant form of PCI, before the widespread use of stenting.

Top Publications

  1. Crea F, Niccoli G. Ezetimibe and Plaque Regression: Cholesterol Lowering or Pleiotropic Effects?. J Am Coll Cardiol. 2015;66:508-10 pubmed publisher
  2. Canova P, Musumeci G, Rossini R, Gori M, Senni M, Valsecchi O. [The spiral of evil: iatrogenic coronary and aortic dissection]. G Ital Cardiol (Rome). 2017;18:322-324 pubmed publisher
    Iatrogenic coronary and aortic dissection is one of the worst complication during a percutaneous coronary intervention. Nevertheless, it can be approached and effectively resolved by a percutaneous way, sealing the false lumen "entry ..
  3. Cannon C, Bhatt D, Oldgren J, Lip G, Ellis S, Kimura T, et al. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. N Engl J Med. 2017;377:1513-1524 pubmed publisher
    ..Triple antithrombotic therapy with warfarin plus two antiplatelet agents is the standard of care after percutaneous coronary intervention (PCI) for patients with atrial fibrillation, but this therapy is associated with a high risk of ..
  4. Fulcher J, O Connell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, et al. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet. 2015;385:1397-405 pubmed publisher
    ..UK Medical Research Council, British Heart Foundation, Australian National Health and Medical Research Council, European Community Biomed Program. ..
  5. Brener S, Mehran R, Dangas G, Ohman E, Witzenbichler B, Zhang Y, et al. Relation of Baseline Hemoglobin Levels and Adverse Events in Patients With Acute Coronary Syndromes (from the Acute Catheterization and Urgent Intervention Triage strategY and Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial. Am J Cardiol. 2017;119:1710-1716 pubmed publisher
    ..In conclusion, in patients with ACS, baseline hemoglobin carries important independent prognostic information and demonstrates a nonlinear association with major bleeding and mortality. ..
  6. Partida R, Yeh R. Contemporary Drug-Eluting Stent Platforms: Design, Safety, and Clinical Efficacy. Cardiol Clin. 2017;35:281-296 pubmed publisher
    ..These design improvements and features are explored, and their resulting clinical safety and efficacy reviewed, focusing on platforms approved by the Food and Drug Administration currently widely used in the United States. ..
  7. Dashwood A, Saw J, Dhillon P, Murdoch D. Use of a Three-Stent Technique for a Case of Spontaneous Coronary Artery Dissection. Can J Cardiol. 2017;33:830.e13-830.e15 pubmed publisher
    ..Our case represents the second such "sequential stent-sandwiching" report and provides a strategy for percutaneous coronary intervention in hemodynamically unstable patients with SCAD.
  8. Camargo G, Rothstein T, Derenne M, Sabioni L, Lima J, Lima R, et al. Factors Associated With Coronary Artery Disease Progression Assessed By Serial Coronary Computed Tomography Angiography. Arq Bras Cardiol. 2017;108:396-404 pubmed publisher
    ..of CAD progression, we excluded patients who had undergone surgical revascularization previously or percutaneous coronary intervention (PCI) between studies...
  9. Garg P, Broadbent D, Swoboda P, Foley J, Fent G, Musa T, et al. Acute Infarct Extracellular Volume Mapping to Quantify Myocardial Area at Risk and Chronic Infarct Size on Cardiovascular Magnetic Resonance Imaging. Circ Cardiovasc Imaging. 2017;10: pubmed publisher
    ..Acute ECV maps were superior to acute LGE in terms of agreement with final IS. IS quantified by ECV maps are independently associated with viability at follow-up. ..

More Information

Publications114 found, 100 shown here

  1. Kwok C, Wong C, Shufflebotham H, Brindley L, Fatima T, Shufflebotham A, et al. Early Readmissions After Acute Myocardial Infarction. Am J Cardiol. 2017;120:723-728 pubmed publisher
    ..patients were more likely to be older, anemic, and less likely to receive coronary angiogram and percutaneous coronary intervention. After adjustment, the only predictor of all-cause readmission was older age...
  2. Moscarella E, Spitaleri G, Brugaletta S, Sentí Farrarons S, Pernigotti A, Ortega Paz L, et al. Impact of Body Mass Index on 5-Year Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction After Everolimus-Eluting or Bare-Metal Stent Implantation. Am J Cardiol. 2017;120:1460-1466 pubmed publisher
    Patients with high body mass index (BMI) seem to have better outcomes after percutaneous coronary intervention than normal-weight patients...
  3. Enezate T, Omran J, Al Dadah A, Alpert M, Mahmud E, Patel M, et al. Comparison of Outcomes of ST-Elevation Myocardial Infarction Treated by Percutaneous Coronary Intervention During Off-Hours Versus On-Hours. Am J Cardiol. 2017;120:1742-1754 pubmed publisher
    ..Only studies comparing STEMI outcomes during off-hours versus on-hours with percutaneous coronary intervention were included. A random-effects meta-analysis model was used to pool outcomes across the studies...
  4. Rosillo S, Lopez de Sa E, Iniesta A, de Torres F, Del Prado S, Rey J, et al. Is therapeutic hypothermia a risk factor for stent thrombosis?. J Am Coll Cardiol. 2014;63:939-40 pubmed publisher
  5. Liu Z, Wang Y, Hua Q, Chu Y, Ji X. Late remote ischemic preconditioning provides benefit to patients undergoing elective percutaneous coronary intervention. Cell Biochem Biophys. 2014;70:437-42 pubmed
    ..is effective in myocardial protection in patients with ischemic heart disease undergoing elective percutaneous coronary intervention (PCI). L-RIPC is exerted by newly synthesized cardioprotective proteins...
  6. Duan C, Cao Y, Liu Y, Zhou L, Ping K, TAN M, et al. A New Preprocedure Risk Score for Predicting Contrast-Induced Acute Kidney Injury. Can J Cardiol. 2017;33:714-723 pubmed publisher
    ..characteristics for early prediction of CI-AKI in patients after coronary angiography or percutaneous coronary intervention (PCI)...
  7. Adriaenssens T, Joner M, Godschalk T, Malik N, Alfonso F, Xhepa E, et al. Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis: A Report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort). Circulation. 2017;136:1007-1021 pubmed publisher
    ..The most frequent dominant observation varied according to time intervals from index stenting: uncovered struts and underexpansion in acute/subacute ST and neoatherosclerosis and uncovered struts in late/very late ST. ..
  8. Makaryus A, Jauhar R, Tortez L, Pekmezaris R. Comparison of the Diameters of the Major Epicardial Coronary Arteries by Angiogram in Asian-Indians Versus European Americans <40 Years of Age Undergoing Percutaneous Coronary Artery Intervention. Am J Cardiol. 2017;120:924-926 pubmed publisher
  9. Waksman R, Kitabata H, Prati F, Albertucci M, Mintz G. Intravascular ultrasound versus optical coherence tomography guidance. J Am Coll Cardiol. 2013;62:S32-40 pubmed publisher
  10. Tumscitz C, Pirani L, Tebaldi M, Campo G, Biscaglia S. Seven french radial artery access for PCI: a prospective single-center experience. Int J Cardiol. 2014;176:1074-5 pubmed publisher
  11. Parato V, Olivotto I, Maron M, Nanda N, Pandian N. Left Ventricular Apex Involvement in Hypertrophic Cardiomyopathy. Echocardiography. 2015;32:1575-80 pubmed publisher
  12. Götberg M, Christiansen E, Gudmundsdóttir I, Sandhall L, Danielewicz M, Jakobsen L, et al. Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI. N Engl J Med. 2017;376:1813-1823 pubmed publisher
    ..Funded by Philips Volcano; iFR SWEDEHEART ClinicalTrials.gov number, NCT02166736 .). ..
  13. Campo G, Vieceli Dalla Sega F, Pavasini R, Aquila G, Gallo F, Fortini F, et al. Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease. Thromb Haemost. 2017;117:1208-1216 pubmed publisher
    ..Forty-six patients with SCAD and COPD undergoing percutaneous coronary intervention (PCI) were randomly assigned to receive clopidogrel (n=23) or ticagrelor (n=23) on top of standard ..
  14. Ulus T, Senol U, Tahmazov S, İskenderov K, Mutlu F, Cavusoglu Y. High-dose bolus tirofiban versus low-dose bolus in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Turk Kardiyol Dern Ars. 2017;45:126-133 pubmed publisher
    ..size, and clinical outcomes in patients with acute coronary syndrome (ACS) who were undergoing percutaneous coronary intervention (PCI) and received current pharmacoinvasive therapy. Acute coronary syndrome patients (n=271, 85...
  15. Verdoia M, Daffara V, Pergolini P, Rolla R, Marino P, Bellomo G, et al. Vitamin D Binding Protein rs7041 polymorphism and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. Vascul Pharmacol. 2017;93-95:42-47 pubmed publisher
  16. Kerr A, Williams M, White H, Grey C, Jiang Y, Nunn C. 30-day mortality after percutaneous coronary intervention in New Zealand public hospitals (ANZACS-QI 18). N Z Med J. 2017;130:54-63 pubmed
    The aim of this report is to provide hospitals in New Zealand with data about their own outcomes for percutaneous coronary intervention (PCI) procedures and allow comparisons with other New Zealand units and with international data...
  17. Saw J, Humphries K, Aymong E, Sedlak T, Prakash R, Starovoytov A, et al. Spontaneous Coronary Artery Dissection: Clinical Outcomes and Risk of Recurrence. J Am Coll Cardiol. 2017;70:1148-1158 pubmed publisher
    ..1%) were initially treated medically, with only 16.5% or 2.2% undergoing in-hospital percutaneous coronary intervention or coronary artery bypass graft surgery, respectively...
  18. Harold J, Bass T, Bashore T, Brindis R, Brush J, Burke J, et al. ACCF/AHA/SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Co. J Am Coll Cardiol. 2013;62:357-96 pubmed publisher
  19. Abizaid A, Costa J, Gibson C. Bioresorbable vascular scaffolds in daily clinical practice: is the essential really invisible to the eyes?. J Am Coll Cardiol. 2015;65:802-804 pubmed publisher
  20. Matsumoto K, Ehara S, Hasegawa T, Sakaguchi M, Shimada K. Association between duration of coronary occlusion and high-intensity signal on T1-weighted magnetic resonance imaging among patients with angiographic total occlusion. Eur Radiol. 2017;27:3896-3903 pubmed publisher
    ..HIS within occlusion sites is associated with subacute or short-duration total occlusion. • T1-weighted imaging for coronary total occlusion may be useful for intervention strategy. ..
  21. Bundhun P, Yanamala C, Huang W. Comparing Stent Thrombosis associated with Zotarolimus Eluting Stents versus Everolimus Eluting Stents at 1 year follow up: a systematic review and meta-analysis of 6 randomized controlled trials. BMC Cardiovasc Disord. 2017;17:84 pubmed publisher
    ..Increase in the number of patients with cardiovascular diseases treated by Percutaneous Coronary Intervention (PCI) has resulted to a high demand for second generation DES...
  22. Li M, Wang H, Xuan L, Shi X, Zhou T, Zhang N, et al. Associations between P2RY12 gene polymorphisms and risks of clopidogrel resistance and adverse cardiovascular events after PCI in patients with acute coronary syndrome. Medicine (Baltimore). 2017;96:e6553 pubmed publisher
    ..syndrome (ACS) is one of the key causes of recurrent cardiovascular disease (CVD) events after percutaneous coronary intervention (PCI)...
  23. Spitzer E, de Vries T, Cavalcante R, Tuinman M, Rademaker Havinga T, Alkema M, et al. Detecting Periprocedural Myocardial Infarction in Contemporary Percutaneous Coronary Intervention Trials. JACC Cardiovasc Interv. 2017;10:658-666 pubmed publisher
    ..Emphasis on collection of biomarkers, ECG data, and clinical status at baseline may improve the correct identification of PMI triggers. ..
  24. Ertelt K, Brener S, Mehran R, Ben Yehuda O, McAndrew T, Stone G. Comparison of Outcomes and Prognosis of Patients With Versus Without Newly Diagnosed Diabetes Mellitus After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (the HORIZONS-AMI Study). Am J Cardiol. 2017;119:1917-1923 pubmed publisher
    ..events in patients with acute ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention. Outcomes of patients with STEMI and newly diagnosed DM (NDM) are less well described...
  25. Fineschi M, Verna E, Mezzapelle G, Bartolini D, Turiano G, Manari A, et al. Assessing MICRO-vascular resistances via IMR to predict outcome in STEMI patients with multivessel disease undergoing primary PCI (AMICRO): Rationale and design of a prospective multicenter clinical trial. Am Heart J. 2017;187:37-44 pubmed publisher
    ..If IMR significantly correlates with differences in outcome and LV remodeling, it will emerge as a potential prognostic index after PPCI in patients with MVD. ..
  26. Palmerini T, Serruys P, Kappetein A, Genereux P, Riva D, Reggiani L, et al. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients. Am Heart J. 2017;190:54-63 pubmed publisher
    Some but not all randomized controlled trials (RCT) have suggested that percutaneous coronary intervention (PCI) with drug-eluting stents may be an acceptable alternative to coronary artery bypass grafting (CABG) surgery for the treatment ..
  27. Qi G, Sun Q, Xia Y, Wei L. Emergency Percutaneous Coronary Intervention Through the Left Radial Artery is Associated with Less Vascular Complications than Emergency Percutaneous Coronary Intervention Through the Femoral Artery. Clinics (Sao Paulo). 2017;72:1-4 pubmed publisher
    To compare the advantages and disadvantages of emergency percutaneous coronary intervention through the left radial artery with those of emergency percutaneous coronary intervention through the femoral artery...
  28. Hannan E, Zhong Y, Jacobs A, Ling F, Berger P, Walford G, et al. Incomplete revascularization for percutaneous coronary interventions: Variation among operators, and association with operator and hospital characteristics. Am Heart J. 2017;186:118-126 pubmed publisher
    ..46, 95% CI 1.07-1.99) than other hospitals. Percutaneous coronary intervention patients without myocardial infarction who undergo IR continue to have higher medium-term (3-year) ..
  29. Shen Q, Wang D, Zhai H, Dong Z, Liu J, Zhang B. [Impact of gender and age on in-hospital major adverse cardiovascular and cerebrovascular events of patients with acute ST-segment elevation myocardial infarction]. Zhonghua Xin Xue Guan Bing Za Zhi. 2017;45:288-293 pubmed publisher
    ..5)years, P<0.001). Compared with male patients, less female patients received primary percutaneous coronary intervention (50.9%(144/283) vs. 70.9%(581/819), P<0.001), had higher rates of in hospital death(10...
  30. Tröbs M, Achenbach S, Plank P, Marwan M, Röther J, Klinghammer L, et al. Predictors of Technical Failure in Transradial Coronary Angiography and Intervention. Am J Cardiol. 2017;120:1508-1513 pubmed publisher
    ..In conclusion, female sex, higher age, and smaller height independently predict transradial access failure in coronary angiography and intervention. Failure rate in ST-elevation myocardial infarction is not significantly increased. ..
  31. Lee T, Hsuan C, Shih C, Liang H, Tsai H, Tseng W, et al. Early detection of myocardial infarction following blunt chest trauma by computed tomography: a case report. BMC Cardiovasc Disord. 2017;17:56 pubmed publisher
    ..This valuable sign should not be missed during the initial interpretation. ..
  32. Stähli B, Gebhard C, Gick M, Ferenc M, Mashayekhi K, Buettner H, et al. Comparison of Outcomes in Men Versus Women After Percutaneous Coronary Intervention for Chronic Total Occlusion. Am J Cardiol. 2017;119:1931-1936 pubmed publisher
    ..stenting, and gender-based data in patients with chronic total occlusions (CTO) who underwent percutaneous coronary intervention (PCI) are scarce...
  33. Wang Y, Li T, Liu Y, Liu B, Hu X, Wang Y, et al. [Effect of the ischemic post-conditioning on the prevention of the cardio-renal damage in patients with acute ST-segment elevation myocardial infarction after primary percutaneous coronary intervention]. Zhonghua Xin Xue Guan Bing Za Zhi. 2017;45:277-282 pubmed publisher
    ..damage in patients with acute ST-segment elevation myocardial infarction (STEMI) after primary percutaneous coronary intervention (PPCI)...
  34. Lønborg J, Engstrøm T, Ahtarovski K, Nepper Christensen L, Helqvist S, Vejlstrup N, et al. Myocardial Damage in Patients With Deferred Stenting After STEMI: A DANAMI-3-DEFER Substudy. J Am Coll Cardiol. 2017;69:2794-2804 pubmed publisher
    ..outcome in patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) and deferred stenting...
  35. Zhao Y, Yu B, Liu Y, Liu Y. Meta-Analysis of the Effect of Obstructive Sleep Apnea on Cardiovascular Events After Percutaneous Coronary Intervention. Am J Cardiol. 2017;120:1026-1030 pubmed publisher
    ..publications to assess the influence of OSA on cardiovascular survival among patients who underwent percutaneous coronary intervention. Eleven eligible publications, including 3,008 participants, were finally evaluated...
  36. Head S, Farooq V, Serruys P, Kappetein A. The SYNTAX score and its clinical implications. Heart. 2014;100:169-77 pubmed publisher
  37. Dehmer G, Blankenship J, Cilingiroglu M, Dwyer J, Feldman D, Gardner T, et al. SCAI/ACC/AHA expert consensus document: 2014 update on percutaneous coronary intervention without on-site surgical backup. Circulation. 2014;129:2610-26 pubmed publisher
  38. Gargiulo G, Mangiameli A, Granata F, Ohno Y, Chisari A, Capodanno D, et al. New-onset coronary aneurism and late-acquired incomplete scaffold apposition after full polymer jacket of a chronic total occlusion with bioresorbable scaffolds. JACC Cardiovasc Interv. 2015;8:e41-e43 pubmed publisher
  39. Bonello L, Dignat George F, Laine M. Personalized Antiplatelet Therapy: The Odyssey Continues. JACC Cardiovasc Interv. 2016;9:105-106 pubmed publisher
  40. Muhyieddeen K, Samim A, Roberts M, Srikanth S. A Case of Iatrogenic Aortic Intramural Hematoma. Methodist Debakey Cardiovasc J. 2017;13:37-38 pubmed publisher
    Iatrogenic aortic dissection during percutaneous coronary intervention is a rare but serious complication. Both conservative and surgical approaches have been proposed as management strategies...
  41. Joyce E, Hoogslag G, Kamperidis V, Debonnaire P, Katsanos S, Mertens B, et al. Relationship Between Myocardial Function, Body Mass Index, and Outcome After ST-Segment-Elevation Myocardial Infarction. Circ Cardiovasc Imaging. 2017;10: pubmed publisher
    ..First patients with STEMI undergoing primary percutaneous coronary intervention (n=1604; mean age, 61±12 years; 75% men) had BMI measured on admission, and 2-dimensional ..
  42. Alnsasra H, Zahger D, Geva D, Matetzky S, Beigel R, Iakobishvili Z, et al. Contemporary Determinants of Delayed Benchmark Timelines in Acute Myocardial Infarction in Men and Women. Am J Cardiol. 2017;120:1715-1719 pubmed publisher
    ..FMC-to-electrocardiogram >10 minutes in ST-elevation MI (STEMI) and non-STEMI, FMC-to-primary percutaneous coronary intervention >90 minutes in STEMI, and invasive angiography >72 hours after admission in non-STEMI patients...
  43. Jaguszewski M, Wyss C, Alibegovic J, Luscher T, Templin C. Acute thrombosis of bioabsorbable scaffold in a patient with acute coronary syndrome. Eur Heart J. 2013;34:2046 pubmed publisher
  44. Coons J, Iasella C, Chanas T, Wang N, Williams K, Boyd A, et al. Comparative Effectiveness and Safety Analysis of Dual Antiplatelet Therapies Within an Integrated Delivery System. Ann Pharmacother. 2017;51:649-655 pubmed publisher
    Dual antiplatelet therapy is a mainstay of care for percutaneous coronary intervention (PCI) patients; however, uncertainty exists in real-world practice about comparative effectiveness and safety outcomes...
  45. Liu D, Borlotti A, Viliani D, Jerosch Herold M, Alkhalil M, De Maria G, et al. CMR Native T1 Mapping Allows Differentiation of Reversible Versus Irreversible Myocardial Damage in ST-Segment-Elevation Myocardial Infarction: An OxAMI Study (Oxford Acute Myocardial Infarction). Circ Cardiovasc Imaging. 2017;10: pubmed publisher
    ..A single CMR acquisition of native T1 mapping could potentially represent a fast, safe, and accurate method for early stratification of acute patients in need of more aggressive treatment. Further confirmatory studies will be needed. ..
  46. Gong X, Tang S, Li J, Zhang X, Tian X, Ma S. Antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis. PLoS ONE. 2017;12:e0186449 pubmed publisher
    ..was to evaluate the comparative efficacy and safety of antiplatelet agents, vitamin K antagonist (VKA) and non-VKA oral anticoagulants (NOACs) in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI).
  47. Wnent J, Seewald S, Heringlake M, Lemke H, Brauer K, Lefering R, et al. Choice of hospital after out-of-hospital cardiac arrest--a decision with far-reaching consequences: a study in a large German city. Crit Care. 2012;16:R164 pubmed publisher
    ..Admitting hospitals were divided into two groups: those without the capability for percutaneous coronary intervention (PCI), and those with PCI capability...
  48. Magalhães T, Lima J. Defining the flow-limiting stenosis noninvasively for management of patients with coronary artery disease. JACC Cardiovasc Interv. 2014;7:79-80 pubmed publisher
  49. Sartorius B, Behnes M, Ünsal M, Hoffmann U, Lang S, Mashayekhi K, et al. Arterial access-site complications after use of a vascular closure device related to puncture height. BMC Cardiovasc Disord. 2017;17:64 pubmed publisher
    ..to the height of femoral arterial puncture and the use of a vascular closure device (VCD) following percutaneous coronary intervention (PCI)...
  50. Slottosch I, Liakopoulos O, Kuhn E, Deppe A, Scherner M, Mader N, et al. Outcome after coronary bypass grafting for coronary complications following coronary angiography. J Surg Res. 2017;210:69-77 pubmed publisher
    Coronary complications during coronary angiography or intervention (percutaneous coronary intervention [PCI]) are uncommon...
  51. Kim Y, Her A, Rha S, Choi B, Shim M, Choi S, et al. Three-Year Major Clinical Outcomes of Angiography-Guided Single Stenting Technique in Non-Complex Left Main Coronary Artery Diseases. Int Heart J. 2017;58:704-713 pubmed publisher
    ..clinical outcome data concerning angiography- versus intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) in non-complex left main coronary artery (LMCA) disease treated with the single stenting ..
  52. Kajita A, Oliveira M, Menezes F, Franken M, Baraciolli L, Nicolau J. Giant and Calcified Post-Infarction True Left Ventricular Aneurysm: What to Do?. Arq Bras Cardiol. 2016;106:259-62 pubmed publisher
  53. Khan A, Golwala H, Tripathi A, Riaz H, Kumar A, Flaherty M, et al. Meta-analysis of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease. Am J Cardiol. 2017;119:1949-1956 pubmed publisher
    Despite the increase in use of percutaneous coronary intervention (PCI) in left main coronary disease, its efficacy compared with coronary artery bypass grafting (CABG) is unclear...
  54. Dai J, Lyu S, Song X, Zhang M, Nie S, Gao H, et al. Stent Versus Non-Stent in Treating Intermediate Stenosis Culprit Lesions in Acute ST-Segment Elevation Myocardial Infarction Patients. Int Heart J. 2017;58:357-364 pubmed publisher
    ..27), and bleeding (1.3% versus 1.2%, P = 1) rates.Stent implantation has a better efficacy and safety in reducing adverse ischemia events in acute STEMI patients with single vessel disease and intermediate stenosis culprit lesions. ..
  55. Zambetti B, Thomas F, Hwang I, Brown A, Chumpia M, Ellis R, et al. A web-based tool to predict acute kidney injury in patients with ST-elevation myocardial infarction: Development, internal validation and comparison. PLoS ONE. 2017;12:e0181658 pubmed publisher
    ..By identifying patients at increased risk, this tool may help physicians tailor post-procedural diagnostic and therapeutic strategies after STEMI to reduce AKI and its associated morbidity and mortality. ..
  56. Erlinge D, Omerovic E, Frobert O, Linder R, Danielewicz M, Hamid M, et al. Bivalirudin versus Heparin Monotherapy in Myocardial Infarction. N Engl J Med. 2017;377:1132-1142 pubmed publisher
    ..has not been clearly established in patients with acute myocardial infarction who are undergoing percutaneous coronary intervention (PCI) according to current practice, which includes the use of radial-artery access for PCI and ..
  57. Yeoh J, Yudi M, Andrianopoulos N, Yan B, Clark D, Duffy S, et al. Evolution of Australian Percutaneous Coronary Intervention (from the Melbourne Interventional Group [MIG] Registry). Am J Cardiol. 2017;120:47-54 pubmed publisher
    b>Percutaneous coronary intervention (PCI) continues to evolve with shifting patient demographics, treatments, and outcomes. We sought to document the specific changes observed over a 9-year period in a contemporary Australian PCI cohort...
  58. Durante A, Laricchia A, Benedetti G, Esposito A, Margonato A, Rimoldi O, et al. Identification of High-Risk Patients After ST-Segment-Elevation Myocardial Infarction: Comparison Between Angiographic and Magnetic Resonance Parameters. Circ Cardiovasc Imaging. 2017;10:e005841 pubmed publisher
    ..Another novel finding of our study is a significantly increased rate of clinically driven target lesion revascularization in the index event culprit vessel in patients with MVO. ..
  59. Piccolo R, Gargiulo G, Franzone A, Santucci A, Ariotti S, Baldo A, et al. Use of the Dual-Antiplatelet Therapy Score to Guide Treatment Duration After Percutaneous Coronary Intervention. Ann Intern Med. 2017;167:17-25 pubmed publisher
    ..patients more likely to derive harm (score <2) or benefit (score ?2) from prolonged DAPT after percutaneous coronary intervention (PCI). To evaluate the safety and efficacy of DAPT duration according to DAPT score...
  60. Amano H, Saito D, Yabe T, Okubo R, Toda M, Ikeda T. Efficacy and Safety of Triple Therapy and Dual Therapy With Direct Oral Anticoagulants Compared to Warfarin. Int Heart J. 2017;58:570-576 pubmed publisher
    ..1%).Triple therapy and dual therapy with DOAC were not inferior to triple therapy and dual therapy with warfarin in terms of major bleeding, benefit outcomes, and thromboembolism. Bleeding mainly occurred in the late phase. ..
  61. Wei J, Mehta P, Grey E, Garberich R, Hauser R, Bairey Merz C, et al. Sex-based differences in quality of care and outcomes in a health system using a standardized STEMI protocol. Am Heart J. 2017;191:30-36 pubmed publisher
    ..Using a prospective regional percutaneous coronary intervention (PCI)-based STEMI system database with a standardized STEMI protocol, we evaluated baseline ..
  62. O Gara P, Kushner F, Ascheim D, Casey D, Chung M, de Lemos J, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:529-55 pubmed publisher
  63. Nallamothu B, Tommaso C, Anderson H, Anderson J, Cleveland J, Dudley R, et al. ACC/AHA/SCAI/AMA-Convened PCPI/NCQA 2013 Performance Measures for Adults Undergoing Percutaneous Coronary Intervention: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures, the Society for Card. Circulation. 2014;129:926-49 pubmed publisher
  64. Loo G, Koo C, Zhang J, Li R, Sethi R, Ong T, et al. Impact of obstructive sleep apnea on cardiovascular outcomes in patients treated with percutaneous coronary intervention: rationale and design of the sleep and stent study. Clin Cardiol. 2014;37:261-9 pubmed
    ..investigating the relationships between OSA and cardiovascular outcomes in patients treated with percutaneous coronary intervention (PCI)...
  65. Nakatani S, Ishibashi Y, Suwannasom P, Grundeken M, Høj Christiansen E, Onuma Y, et al. Development and receding of a coronary artery aneurysm after implantation of a fully bioresorbable scaffold. Circulation. 2015;131:764-7 pubmed publisher
  66. Posma R, Lexis C, Lipsic E, Nijsten M, Damman K, Touw D, et al. Effect of Metformin on Renal Function After Primary Percutaneous Coronary Intervention in Patients Without Diabetes Presenting with ST-elevation Myocardial Infarction: Data from the GIPS-III Trial. Cardiovasc Drugs Ther. 2015;29:451-9 pubmed
  67. Allen D, Ma B, Leung K, Graham M, Pannu N, Traboulsi M, et al. Risk Prediction Models for Contrast-Induced Acute Kidney Injury Accompanying Cardiac Catheterization: Systematic Review and Meta-analysis. Can J Cardiol. 2017;33:724-736 pubmed publisher
    ..that developed or validated a clinical prediction model for CI-AKI or dialysis after angiography or percutaneous coronary intervention. Random effects meta-analysis was used to pool c-statistics of models...
  68. Barton G, Irvine L, Flather M, McCann G, Curzen N, Gershlick A. Economic Evaluation of Complete Revascularization for Patients with Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention. Value Health. 2017;20:745-751 pubmed publisher
    ..infarct-related artery (IRA) treatment only, in patients with multivessel disease undergoing primary percutaneous coronary intervention (P-PCI) for ST-segment elevation myocardial infarction...
  69. Chang M, Lee C, Ahn J, Cavalcante R, Sotomi Y, Onuma Y, et al. Comparison of Outcome of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation for Non-ST-Elevation Acute Coronary Syndrome. Am J Cardiol. 2017;120:380-386 pubmed publisher
    There is limited data comparing effectiveness of coronary artery bypass grafting (CABG) versus percutaneous coronary intervention (PCI) with drug-eluting stents in patients with non-ST-elevation acute coronary syndromes (NSTE-ACS)...
  70. Sciahbasi A, Rigattieri S, Sarandrea A, Cera M, Di Russo C, Fedele S, et al. Determinants of operator radiation exposure during percutaneous coronary procedures. Am Heart J. 2017;187:10-18 pubmed publisher
    ..The use of adjunctive anti-rx drapes seems a valuable tool to reduce the higher operator radiation exposure associated with TRA. ..
  71. Gili S, D Ascenzo F, di Summa R, Conrotto F, Cerrato E, Chieffo A, et al. Radial Versus Femoral Access for the Treatment of Left Main Lesion in the Era of Second-Generation Drug-Eluting Stents. Am J Cardiol. 2017;120:33-39 pubmed publisher
    ..Consecutive patients who underwent percutaneous coronary intervention on ULM with second-generation drug-eluting stents were retrospectively enrolled in the multicenter ..
  72. Dangoisse V, Guédès A, Chenu P, Hanet C, Albert C, Robin V, et al. Usefulness of a Gentle and Short Hemostasis Using the Transradial Band Device after Transradial Access for Percutaneous Coronary Angiography and Interventions to Reduce the Radial Artery Occlusion Rate (from the Prospective and Randomized CRASOC I, I. Am J Cardiol. 2017;120:374-379 pubmed publisher
    ..About 8% of patients required more than the 1.5 hours of hemostasis time. In conclusion, short and soft hemostasis with the TR Band device leads to a low RAO rate. ..
  73. Hwang K, Eom S, Lee S, Kim S, Cho M, Kim Y, et al. Atrial Fibrillation on Admission Is Related With Higher Mortality in ST-Segment Elevation Myocardial Infarction Patients. Int Heart J. 2017;58:486-494 pubmed publisher
    ..rhythm or AF) on emergency room arrival, < 12 hours of symptom onset, and who underwent primary percutaneous coronary intervention (PCI) within 90 minutes of arriving at the hospital...
  74. Shavelle D, Bosson N, Thomas J, Kaji A, Sung G, French W, et al. Outcomes of ST Elevation Myocardial Infarction Complicated by Out-of-Hospital Cardiac Arrest (from the Los Angeles County Regional System). Am J Cardiol. 2017;120:729-733 pubmed publisher
    The objective of this study was to evaluate the time to primary percutaneous coronary intervention (PCI) and the outcome for patients with ST elevation myocardial infarction (STEMI) complicated by out-of-hospital cardiac arrest (OHCA)...
  75. Proietti M, Airaksinen K, Rubboli A, Schlitt A, Kiviniemi T, Karjalainen P, et al. Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry. Am Heart J. 2017;190:86-93 pubmed publisher
    ..oral anticoagulation (OAC) and antiplatelets is used in atrial fibrillation (AF) patients undergoing percutaneous coronary intervention and stent (PCI-S) procedure but is associated with increased bleeding when triple antithrombotic ..
  76. Li K, Yu S, Zhuge B. PIK3CG single nucleotide polymorphisms are associated with poor responsiveness to clopidogrel and increased risk of ischemia in patients with coronary heart disease. Medicine (Baltimore). 2017;96:e7566 pubmed publisher
    ..study consisted of 513 CHD patients who received clopidogrel as part of antiplatelet therapy, after percutaneous coronary intervention. According to the patient responsiveness to clopidogrel, the subjects were assigned to either ..
  77. Bass T. Interventional Cardiology US Workforce: current challenges. Circ Cardiovasc Interv. 2014;7:733-5 pubmed publisher
  78. Lee W, Chung W, Fang H, Wu C. Coronary artery aneurysms formation within Everolimus-eluting stents and bioresorbable vascular scaffolds. Int J Cardiol. 2016;206:58-60 pubmed publisher
  79. Agarwal N, Jain A, Mahmoud A, Bishnoi R, Golwala H, Karimi A, et al. Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention. Am J Med. 2017;130:1280-1289 pubmed publisher
    ..single antiplatelet therapy and anticoagulant) in patients taking long-term anticoagulants after percutaneous coronary intervention. Major bleeding was the primary outcome...
  80. Wu Y, Zhang X, Tian L, Jiang J, Xu L, Huang Y, et al. [Impact of CYP2C19 genotype and platelet function on clinical outcome in coronary atherosclerotic heart diseases patients received clopidogrel post percutaneous coronary intervention]. Zhonghua Xin Xue Guan Bing Za Zhi. 2017;45:377-385 pubmed publisher
    ..including bleeding events of coronary artery disease(CAD) patients received clopidogrel post percutaneous coronary intervention(PCI)...
  81. Marazzi G, Campolongo G, Pelliccia F, Quattrino S, Vitale C, Cacciotti L, et al. Comparison of Low-Dose Statin Versus Low-Dose Statin?+?Armolipid Plus in High-Intensity Statin-Intolerant Patients With a Previous Coronary Event and Percutaneous Coronary Intervention (ADHERENCE Trial). Am J Cardiol. 2017;120:893-897 pubmed publisher
    ..group, single-blind trial in which participants had coronary artery disease (n?=?100), had undergone percutaneous coronary intervention in the preceding 12 months, were high-dose statin intolerant, and did not achieve ?50% reduction in ..
  82. Markus H, Larsson S, Kuker W, Schulz U, Ford I, Rothwell P, et al. Stenting for symptomatic vertebral artery stenosis: The Vertebral Artery Ischaemia Stenting Trial. Neurology. 2017;89:1229-1236 pubmed publisher
    ..This study provides Class I evidence that for patients with symptomatic vertebral stenosis, angioplasty with stenting does not reduce the risk of stroke. However, the study lacked the precision to exclude a benefit from stenting. ..
  83. Levine G, Bates E, Blankenship J, Bailey S, Bittl J, Cercek B, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventio. Catheter Cardiovasc Interv. 2013;82:E266-355 pubmed publisher
  84. Meier B, Blaauw Y, Khattab A, Lewalter T, Sievert H, Tondo C, et al. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. Europace. 2014;16:1397-416 pubmed publisher
  85. Sardella G, Calcagno S, Mancone M, Lucisano L, Pennacchi M, Stio R, et al. Comparison of therapy with Ticagrelor, Prasugrel or high Clopidogrel dose in PCI patients with high on treatment platelet reactivity and genotype variation. TRIPLETE RESET trial. Int J Cardiol. 2015;194:60-2 pubmed publisher
  86. Banerjee S, Angiolillo D, Boden W, Murphy J, Khalili H, HASAN A, et al. Use of Antiplatelet Therapy/DAPT for Post-PCI Patients Undergoing Noncardiac Surgery. J Am Coll Cardiol. 2017;69:1861-1870 pubmed publisher
    ..This review presents 3 commonly encountered clinical scenarios that lead into an evidence-based discussion of practical strategies for managing perioperative antiplatelet therapy in patients following percutaneous coronary intervention.
  87. Kedhi E, Fabris E, van der Ent M, Kennedy M, Buszman P, von Birgelen C, et al. A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the "DAPT-STEMI trial". Am Heart J. 2017;188:11-17 pubmed publisher
    The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention with second-generation drug eluting stents (DESs) is unclear...
  88. Tscharre M, Egger F, Machata M, Rohla M, Michael N, Neumayr M, et al. Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registry. PLoS ONE. 2017;12:e0179349 pubmed publisher
    ..Parameters associated with a presumably higher risk of bleeding and side-effects against the more effective P2Y12 inhibitors were the most prominent factors for the prescription of clopidogrel. ..
  89. Kim J, Roh Y, Park Y, Park J, Joung B, Park I, et al. Risk score to predict false-positive ST-segment elevation myocardial infarction in the emergency department: a retrospective analysis. Scand J Trauma Resusc Emerg Med. 2017;25:61 pubmed publisher
    The best treatment approach for ST-segment elevation myocardial infarction (STEMI) is prompt primary percutaneous coronary intervention (PCI)...
  90. Gossl M, Faxon D, Bell M, Holmes D, Gersh B. Complete versus incomplete revascularization with coronary artery bypass graft or percutaneous intervention in stable coronary artery disease. Circ Cardiovasc Interv. 2012;5:597-604 pubmed publisher
  91. Spencer F, Prasad M, Vandvik P, Chetan D, Zhou Q, Guyatt G. Longer- Versus Shorter-Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement: A Systematic Review and Meta-analysis. Ann Intern Med. 2015;163:118-26 pubmed publisher
    ..Because absolute effects are very small and closely balanced, decisions regarding the duration of DAPT therapy must take into account patients' values and preference. None. ..
  92. Noble S. Radial Access in Patients Invasively Treated for Acute Coronary Syndromes: A Lifesaving Approach. JACC Cardiovasc Interv. 2016;9:671-3 pubmed publisher